Intervention not reported
All‐cause mortality at day 28 · unvaccinated, non‐hospitalized people with mild symptomatic COVID‐19 (WHO scale 2 to 3) at high risk for progression to severe disease
The intervention may leads to lower all‐cause mortality at day 28 (low certainty).
1 finding from 1 review
- Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19 2023 · Cochrane Headline outcomes onlyRR 0.04 [0, 0.68]1 study · 2224 participantsLow